Back

Predicting Future SARS-CoV-2 Mutations using Deep Learning

Ayaz, H.; Ibrahimzada, A. R.; Adebali, O.; Fejzullahu, A.; Azgari, C.; Baysan, M.; Buyukbingol, M. E.; Demir, G.; Karlik, E.; Ozpolat, B.; CAKMAK, A.

2025-07-15 bioinformatics
10.1101/2025.07.12.664533 bioRxiv
Show abstract

SARS-CoV-2 continues to spread over the world steadily as opposed to many earlier estimations that it would disappear in less than two years. Even though SARS-CoV-2 vaccines have reduced the speed of the infection significantly, they could not fully stop it. On the contrary, the World Health Organization has recently published cautionary statements that infection counts are on the rise, and a huge wave is expected in winter. Vaccines mostly target specific regions of the virus. The high mutation rate of SARS-CoV-2 is one essential tool that the virus exploits to escape from the available vaccines. Therefore, researchers have been working on designing next-generation vaccines against the new variants of the virus. Nevertheless, SARS-CoV-2 acquires new mutations faster than we can adapt our vaccines due to long clinical trial periods. Hence, there is a need for computational tools that can predict future SARS-CoV-2 mutations before they even emerge. In this paper, we propose several deep-learning-based methods to estimate the possible future mutations in SARS-CoV-2 genome. We design and evaluate various ensemble and bagging architectures enriched with a large set of genomic, biochemical, and phylogenetic features. We evaluate our models on the GISAID data and demonstrate that the best-performing methods achieve an F1-Macro score of 0.78.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.